Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Boehringer Ingelheim
Age
12–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with least one asthma diagnosis in the inpatient setting or at least two separate instances of asthma diagnosis (separated by at least 30 days) recorded in the outpatient or emergency room setting will be included.
Patients will be required to be already on Inhaled Corticosteroid/Long-acting beta-agonist (ICS/LABA).
Patients will be required to have available records 12 months prior to the index date.
You may not be if
Patients below the age of 6 years on the Inhaled Corticosteroid/Long-acting beta-agonist initiation (ICS/LABAi) date will be excluded.
Patients with a diagnosis of COPD at any time during the study period will be excluded.
Those who are on biologics at baseline will be removed.
After the PSM process, unmatched patients will be excluded.
Clareo Health | Impact of Tiotropium Add-on Therapy in Patients With Asthma
